It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
According to NPR, “Canadian border patrol has effectively prevented caravans of Americans” from crossing the border. Most are arriving by sailboats and luxury yachts.
Those crossing the border have often told officials that they are heading to Alaska to circumvent the new regulations. But because so many Americans are using the so-called “Alaska loophole,” authorities have increased restrictions.
One reason Americans are being spotted is that Canadian boaters are using technology to monitor them. With the requirement that all passenger boats have to be equipped with tracking devices to help prevent weather-related accidents, anyone with an internet connection can monitor border-crossings and identify vessels by type and country of origin.
According to a 2019 report by the OECD group of industrialised nations, the US spends roughly twice the average amount spent by other member countries on pharmaceuticals per head. For example, where the UK paid £398 ($497) per head in 2015, the USA paid $1,162.
Since taking office, Mr Trump has made repeated attacks against those who set drug prices and has pledged to take radical steps to reduce them.
But with the presidential election just several months away, industry experts have voiced doubts that any major decisions could come into force before the 3 November vote.
They also say that the White House has limited power to implement drug pricing policies.
Executive orders do not have any automatic legal force and can also be challenged in court.
Surprisingly, option two might give you the best hope for surviving the disease with your health — and your wealth — intact. Not only are cancer patients 2½ times as likely to declare bankruptcy as healthy people, but those patients who go bankrupt are 80 percent more likely to die from the disease than other cancer patients, according to studies from the Fred Hutchinson Cancer Center in Seattle. “For many patients, when they get the bills, it can be as bad as some of the side effects of the disease or the treatment,” says the center’s Gary Lyman, M.D.
New cancer treatments emerge routinely, but with new hope comes even more cost: 11 of the 12 cancer drugs that the Food and Drug Administration approved in 2012 were priced at more than $100,000 per year. Compare that with, say, treating heart disease. Cardio procedures and medicines are well established, and a big part of the solution is lifestyle changes — eating well, exercising and reducing stress. That’s why treating a heart attack may cost around $39,000.
Yes, insurance covers much of cancer’s medical costs. With a good policy, a patient is probably looking at a bill of more than $4,000 in deductibles and copays in a year before costs are fully covered. Medicare patients will have lower deductibles but may still be on the hook for thousands in copays. The costs of treatment itself, though, are only part of the story.
This time she opted for a double mastectomy and reconstructive surgery. “I didn’t want to go through cancer a third time,” she explains. Her first cancer treatment cost about $40,000. Two decades later, the bill was $120,000. Again, she was covered by insurance. But her copays and premiums added up to $25,000 at a time when she couldn’t work. Not included in those costs: lost wages, travel to and from surgery, forfeited revenue from real estate investments she lost to foreclosure, and the incalculable human cost of more suffering.
“We’re the victims of our own success,” says Heffern. People who “beat” cancer often face a whole new round of expenses if it returns, and the costs of treatment can double or triple from one diagnosis to the next. Enter the need for a medical-financial adviser. But like a medical scan that’s fuzzy or inconclusive, so is the picture of a patient’s ability to pay for the most promising treatment.
Sometimes having high income — or life savings — can be the last thing a person wants when the cancer diagnosis comes. At the time of her first cancer, Sleight had a $5,000 CD, a sign of solvency that effectively blocked her access to many services she desperately needed.
In 2011, the U.S. Food and Drug Administration approved several new exciting classes of drugs, including the immune checkpoint inhibitor ipilimumab (Yervoy) for malignant melanoma. That was also the year that the cost of these new therapies broke the $100,000 barrier. By 2014, the average cost of a new oral medication exceeded $135,000.2 This past year, tisagenlecleucel (Kymriah), a chimeric antigen receptor (CAR) T-cell therapy for the treatment of adolescent and young adult acute lymphoblastic leukemia, became the most expensive cancer therapy ever, at $475,000.
Today, I’m proud to announce one of the most important deals in the history of U.S. pharmaceutical industries. My administration has reached a historic agreement with a great American company — you remember this company; it’s called — from the good, old camera age, the old days — to begin producing critical pharmaceutical ingredients. It’s called Kodak. And it’s going to be right here in America. So I want to congratulate the people in Kodak. They’ve been working very hard. Members of my administration are present in Rochester right now — Rochester, New York — a good place. And they’re trying to finalize this groundbreaking deal, and they will be announcing this deal.
I want to thank Governor Andrew Cuomo and his representatives. We’ve worked really well together on this deal. It’s a big deal. It’s going to be a great deal and a great deal for New York and a great deal for Kodak.
Ninety percent of all prescriptions written in the United States are for generic drugs. We have approved more generic drugs than any other administration, by far. Generic drugs can be just as good as the brand names, but cost much less.
Yet, in less than 10 percent of the active pharmaceutical ingredients needed to make these drugs — they’re currently manufactured in America — more than 50 percent, however, are made in India and China. And you’ll be seeing — a lot of things have happened. It’s been happening, but it’s happening at a more rapid pace right now.
With this new agreement, my administration is using the Defense Production Act to provide a $765 million loan to support the launch of Kodak Pharmaceuticals. It’s a great name, when you think of it. Such a great name. It was one of the great brands in the world. Then people went digital, and Kodak didn’t follow. But now, under very extraordinary leadership, they are following and they’re doing something that’s a different field, and it’s a field that they’ve really hired some of the best people in the world to be taking care of that company and watching that company — watching over it. But it’s a breakthrough in bringing pharmaceutical manufacturing back to the United States.
Under this contract, our 33rd use of the Defense Production Act — remember when you were saying I didn’t use it enough, I didn’t use it enough? And now you heard it’s the 33rd use."
originally posted by: SocratesJohnson
Guardians of lies, the Canadian unemployment rate is high than America.
BLM are also being domestic terrorist in Canada too, Antifa is t as bad. The Toronto March demanded to release all criminals. With a liberal, black face, leader....they just might
originally posted by: underwerks
America is truly running like one of Trumps businesses. Only difference is that this time he can’t just dump it once it fails and start another one.
Hope all of you that used that talking point 4 years ago are happy. I still can’t understand how in the hell Republicans screwed everything up so bad that capitalism here looks like communism in a third world hell hole.
Signed a guy who’s angry at supermarket shelves being empty. I want my damn thick cut bacon.
I want my damn thick cut bacon.
America is truly running like one of Trumps businesses.
originally posted by: Middleoftheroad
You guys call Trump a racist for trying to stop illegals from crossing our borders to live off our social programs, run drugs and cartels in our neighborhoods, take our jobs, and kill actual US citizens. Yet, sit here and complain about some sailboats and luxury yachts crossing the border.